Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
US Army
Daiichi Sankyo
Express Scripts

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,083,809

« Back to Dashboard

Summary for Patent: 7,083,809

Title:Purified cytokine inhibitory factor
Abstract: Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-.alpha.), interleukin-1-beta (IL-1.beta.), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.
Inventor(s): Iyer; Subramanian (Hockessin, DE), Johnson; William L. (Wilmington, DE), Nguyen; Lance (Telford, PA), Ross; Steven C. (Wilmington, DE), Xing; Ruye (Avondale, PA)
Assignee: Arkion Life Sciences, LLC (Wilmington, DE)
Application Number:10/364,593
Patent Claim Types:
see list of patent claims
Composition; Use; Formulation; Dosage form; Delivery; Device; Process;

No matches for this query

International Patent Family for Patent: 7,083,809

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1642562► Subscribe
China1279972► Subscribe
European Patent Office1487465► Subscribe
Hong Kong1080749► Subscribe
South Korea20040105710► Subscribe
Brazil0307691► Subscribe
Canada2474360► Subscribe
Australia2003216227► Subscribe
MexicoPA04007694► Subscribe
World Intellectual Property Organization (WIPO)03068152► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Chinese Patent Office
Cantor Fitzgerald
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: